Skip to main content Skip to section navigation Skip to footer
Axogen Corporate Home
    • About Us
    • Management Team
    • Board of Directors
    • Careers
    • Organizations We Work With
    • Grants, Donations and Sponsorships
    • Ethics and Compliance
    • Patents
  • For healthcare professionals
  • For patients
  • For investors
Skip to main content Skip to section navigation Skip to footer
Axogen, Inc. IR Overview
  • Overview
  • News/Events
    • News / Events Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Information
    • Financial Information Overview
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Information
    • Contacts
    • FAQ

Press Releases

Investors

  • Overview
  • News/Events
    • News / Events Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Information
    • Financial Information Overview
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Information
    • Contacts
    • FAQ

  • News/Events

  • News / Events Overview
  • Press Releases
  • Axogen In the News
  • IR Calendar
  • Clinical Conferences
  • Presentations
  • Email Alerts
Feb 2, 2024 4:15 pm EST
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Jan 18, 2024 5:00 pm EST
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
Jan 4, 2024 4:45 pm EST
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
Jan 4, 2024 4:40 pm EST
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
Jan 4, 2024 4:35 pm EST
Axogen Announces Promotions on Research and Development Team
Dec 26, 2023 4:15 pm EST
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
Dec 6, 2023 7:00 am EST
Axogen Announces Transition of Finance Team Leadership
Dec 1, 2023 5:00 pm EST
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 20, 2023 7:00 am EST
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference
Nov 7, 2023 7:00 am EST
Axogen, Inc. Reports 2023 Third Quarter Financial Results
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 36
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
  • accessibilityAccessibility Statement
Axogen Corporate Home

13631 Progress Blvd, Suite 400
Alachua, FL 32615

Audience
  • For Healthcare Professionals
  • For Patients
  • For Investors
Resources
  • Privacy Policy
  • Terms and Conditions
  • Website Terms of Use
  • Medical Information
Corporate
  • About Axogen
  • Careers
  • Contact
  • News
YouTube company logo LinkedIn company logo Instagram company logo Facebook company logo X company logo

© 2026 Axogen Corporation. All Rights Reserved. All trademarks are the property of their respective owners. See Trademark & Copyright Notice for details.